Johnson & Johnson Settlement

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

I think it's a reasonable deal. The victims, the patients, they get compensation. But it always makes me think again about this jury system that they have in the states. So there is no scientific evidence. That's what Johnson & Johnson claims. For me, because we don't know the sciences retail investors, it's really hard to judge who's right and who's not right.

In today's show, we are discussing some great dividend growth stocks from Sweden. Actually, there were enough Swedish dividend stocks to choose from and it shows that the Nordics produce very stable businesses.

So, in today's show, we discussed the following topics:

Johnson & Johnson's talc powder settlement and our thoughts about it
2 dividend hikes from $STZ and $FDX
7 Sweden dividend growth stocks: $AAK.ST, $ASSA-B.ST, $SWEC-B.ST, $WIHL.ST, $VIT-B.ST, $ABB.ST, $EVO.ST
Your listener questions and some of the following stocks were mentioned: $ATCO.ST, $LOOMIS.ST, $AXFO.ST, $HPOL-B.ST, $FRE.DE, $CIBUS.ST, $JM.ST

We hope you enjoyed today's show and feel free to join the discussion in the Dividend Talk Facebook group: https://www.facebook.com/groups/dividendtalk